These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 34870090)
1. Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic. Yap C; Ali A; Prabhakar A; Prabhakar A; Pal A; Lim YY; Kakodkar P Ther Adv Vaccines Immunother; 2021; 9():25151355211059791. PubMed ID: 34870090 [TBL] [Abstract][Full Text] [Related]
2. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
3. Role of COVID-19 Vaccines in SARS-CoV-2 Variants. Zhou Z; Zhu Y; Chu M Front Immunol; 2022; 13():898192. PubMed ID: 35669787 [TBL] [Abstract][Full Text] [Related]
4. Adverse Effects of Pfizer (BioNTech), Oxford-AstraZeneca (ChAdOx1 CoV-19), and Moderna COVID-19 Vaccines among the Adult Population in Saudi Arabia: A Cross-Sectional Study. Aldali J; Meo SA; Al-Khlaiwi T Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851109 [TBL] [Abstract][Full Text] [Related]
5. The COVID-19 pandemic: viral variants and vaccine efficacy. Ciotti M; Ciccozzi M; Pieri M; Bernardini S Crit Rev Clin Lab Sci; 2022 Jan; 59(1):66-75. PubMed ID: 34598660 [TBL] [Abstract][Full Text] [Related]
6. A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson. Patel R; Kaki M; Potluri VS; Kahar P; Khanna D Hum Vaccin Immunother; 2022 Dec; 18(1):2002083. PubMed ID: 35130825 [TBL] [Abstract][Full Text] [Related]
7. Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines. Hvidt AK; Baerends EAM; Søgaard OS; Stærke NB; Raben D; Reekie J; Nielsen H; Johansen IS; Wiese L; Benfield TL; Iversen KK; Mustafa AB; Juhl MR; Petersen KT; Ostrowski SR; Lindvig SO; Rasmussen LD; Schleimann MH; Andersen SD; Juhl AK; Dietz LL; Andreasen SR; Lundgren J; Østergaard L; Tolstrup M; Front Med (Lausanne); 2022; 9():994160. PubMed ID: 36262278 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview. Shiravi AA; Ardekani A; Sheikhbahaei E; Heshmat-Ghahdarijani K Cardiol Ther; 2022 Mar; 11(1):13-21. PubMed ID: 34845662 [TBL] [Abstract][Full Text] [Related]
9. Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection. Costanzo M; De Giglio MAR; Roviello GN Curr Med Chem; 2022; 29(1):4-18. PubMed ID: 34355678 [TBL] [Abstract][Full Text] [Related]
10. [COVID-19 infections and effectiveness of the vaccination among healthcare workers]. Rojkovich B; Németh D; Dinya E; Nagy E; Török E; Lázár I; Perduk A; Géher P; Nagy G Orv Hetil; 2023 Feb; 164(5):163-171. PubMed ID: 36739547 [TBL] [Abstract][Full Text] [Related]
12. Comparative Profiles of SARS-CoV-2 Spike-Specific Human Milk Antibodies Elicited by mRNA- and Adenovirus-Based COVID-19 Vaccines. Yang X; Fox A; DeCarlo C; Norris C; Griffin S; Wedekind S; Flanagan JM; Shenker N; Powell RL Breastfeed Med; 2022 Aug; 17(8):638-646. PubMed ID: 35675683 [No Abstract] [Full Text] [Related]
13. Developmental Status of the Potential Vaccines for the Mitigation of the COVID-19 Pandemic and a Focus on the Effectiveness of the Pfizer-BioNTech and Moderna mRNA Vaccines. Noor R Curr Clin Microbiol Rep; 2021; 8(3):178-185. PubMed ID: 33686365 [TBL] [Abstract][Full Text] [Related]
14. A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations. Chakraborty C; Sharma AR; Bhattacharya M; Lee SS Front Immunol; 2022; 13():801522. PubMed ID: 35222380 [TBL] [Abstract][Full Text] [Related]
15. Safety Profile of COVID-19 Vaccines among Healthcare Workers in Poland. Paczkowska A; Hoffmann K; Michalak M; Hans-Wytrychowska A; Bryl W; Kopciuch D; Zaprutko T; Ratajczak P; Nowakowska E; Kus K Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335066 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of COVID-19 vaccines and their challenges (Review). Marfe G; Perna S; Shukla AK Exp Ther Med; 2021 Dec; 22(6):1407. PubMed ID: 34676000 [TBL] [Abstract][Full Text] [Related]
17. The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2. Jamous YF; Alhomoud DA Cureus; 2023 Sep; 15(9):e45602. PubMed ID: 37868494 [TBL] [Abstract][Full Text] [Related]
18. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia. Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883 [TBL] [Abstract][Full Text] [Related]
19. Review of COVID-19 Vaccines and Their Evidence in Older Adults. Teo SP Ann Geriatr Med Res; 2021 Mar; 25(1):4-9. PubMed ID: 33550776 [TBL] [Abstract][Full Text] [Related]